Records containing: Severe Eosinophilic Asthma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-07-13The Biopsychosocial Impact of Mepolizumab in Severe Eosinophilic Asthma on Quantitative and Qualitative Emotional and Affective Outcomes in Patients and Partners
-
CLINICAL_TRIALS study record update · 2026-04-23STEP: A Prospective, Interventional, Multicenter, Single-Arm Phase 3b Study to Evaluate the Step-Down of Maintenance Therapy in Patients With Severe Eosinophilic Asthma Treated With Benralizumab
-
CLINICAL_TRIALS study record update · 2026-04-17Evaluation of Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis With Nasal Polyps and Comorbid Severe Eosinophilic Asthma: an Integrative Multi-omics Approach to Assess Biomarker Signatures of Responsive Disease Endotypes
-
CLINICAL_TRIALS study record update · 2026-04-15A Real World Multicenter 48 Week Prospective Cohort Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab in Routine Care Settings in Greece
-
CLINICAL_TRIALS study record update · 2026-04-09ItAlian, Multicenter, Observational, Prospective sTudy to Evaluate the acHievement of Clinical rEmission and immuNomodulation in Severe Eosinophilic Asthma Patients Treated With Benralizumab - the ATHENA Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-11Biomarkers Evaluation and Effect of Mepolizumab on Lower and Upper Airways Inflammation in Severe Refractory Eosinophilic Asthma
-
CLINICAL_TRIALS study record update · 2025-10-03Clock Proteins as a Prognostic Marker for Disease Progression
-
CLINICAL_TRIALS study record update · 2025-01-09SHAMAL: A Multicentre, Randomised, Open-Label, Parallel-Group, Active-Controlled, Phase IV Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab
-
CLINICAL_TRIALS study record update · 2024-10-21A Multicenter, Single Arm, Non-interventional, Observational, Prospective Study to Assess Demographic Characteristics, Burden of Disease and Short-term Patient Reported Outcomes on Symptom Relief in Severe Eosinophilic Asthma Patients Aged Older Than 18 Qualifying for Treatment With Benralizumab in Russia
-
CLINICAL_TRIALS study record update · 2024-07-01Patient Outcomes Real World Evidence Registry (POWER): Patient Reported Outcomes in a Cohort of Canadian Adults With Severe Eosinophilic Asthma on Benralizumab.
-
CLINICAL_TRIALS study record update · 2024-02-29Utilisation of Benralizumab in the Clinical Practise in Severe Eosinophilic Asthma Patients in Switzerland
-
CLINICAL_TRIALS study record update · 2023-10-06The Biopsychosocial Impact of Mepolizumab in Severe Eosinophilic Asthma on Quantitative and Qualitative Emotional and Affective Outcomes in Patients and Partners
-
CLINICAL_TRIALS study record update · 2023-04-19Retrospective, Observational Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps Treated by FASENRA®
-
CLINICAL_TRIALS study record update · 2021-06-29Observational Retrospective Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain
-
CLINICAL_TRIALS study record update · 2020-09-09Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma
-
CLINICAL_TRIALS study record update · 2019-09-12ClinicalTrials.gov study NCT04084613
-
CLINICAL_TRIALS study record update · 2019-08-29The Effect of OC000459 on Eosinophilic Airway Inflammation and Asthma Control in Subjects With Refractory Eosinophilic Asthma: a Randomised, Double-blind, Placebo Controlled Trial
-
CLINICAL_TRIALS study record update · 2018-11-13A Prospective Observational Study on the Effect of Mepolizumab add-on Therapy on Daily Physical Activity in Patients With Severe Eosinophilic Asthma
-
CLINICAL_TRIALS study record update · 2018-08-29Impact of Benralizumab Treatment on Circulating Dendritic Cells in Patients With Eosinophilic Asthma